BPC-157 is a synthetic peptide derived from a sequence found in human gastric juice. It has been studied primarily in preclinical models for its potential role in tissue repair and gastrointestinal integrity, and is prescribed under doctor review as a compounded medication.
Format & administration
Most patients are prescribed a daily subcutaneous injection; a nasal spray format is available for patients who prefer a needle-free option. Your doctor sets dosing, cycle length, and any rest periods.
Testing posture
Your doctor determines the final testing requirements for BPC-157 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
How it works
How BPC-157 works
01Researchers have investigated BPC-157 for its potential to influence angiogenesis — the formation of new blood vessels — and to modulate growth factor signaling involved in tissue regeneration.
02It is explored within wellness-focused protocols for its possible contribution to cellular repair pathways.
BPC-157: proposed mechanism, physiology, and reported clinical effects. Educational illustration — not a treatment guarantee.
Show illustration: BPC-157
BPC-157: proposed mechanism, physiology, and reported clinical effects. Educational illustration — not a treatment guarantee.
What has been studied
Potential applications and evidence
These areas are commonly discussed within wellness-focused protocols. They are educational statements, not medical claims or guarantees of outcome.
Potential support for tendon, ligament, and soft tissue recovery
Explored within protocols addressing gut lining integrity
Commonly discussed for joint comfort and mobility
Used alongside structured rehabilitation and training programs
Doctor-guided
A personalized approach
Your doctor determines the final testing requirements for BPC-157 after reviewing your intake. The panels below are what is commonly reviewed for this therapy — they are educational guidance, not a fixed requirement.
Bloodwork status: Provider Determines Testing
Commonly reviewed at baseline
CBC
Comprehensive metabolic panel (CMP)
hs-CRP
Vitamin D
Follow-up & monitoring
Progress is generally tracked by symptom and function response rather than by a specific lab marker. Your doctor sets any recheck interval.
Medication review
Your doctor reviews all prescriptions, supplements, and over-the-counter medications during intake before anything is prescribed.
Format & dosing
Most patients are prescribed a daily subcutaneous injection; a nasal spray format is available for patients who prefer a needle-free option. Your doctor sets dosing, cycle length, and any rest periods.
Safety
What patients should know
BPC-157 is not an FDA-approved drug product; it is compounded for an individual patient pursuant to a valid prescription. It is not appropriate for patients with active malignancy, and should be reviewed carefully alongside pregnancy, nursing, and existing medications.
Who may not be a candidate
Pregnancy or nursing
Active malignancy without oncology clearance
Known hypersensitivity to the preparation
Regulatory status: Compounded. Evidence level: Preclinical. Eligibility, dosing, laboratory requirements, and follow-up care are determined exclusively by a licensed doctor after review of your history.